Taguba, Joesevans .
HRN: 26-72-26 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2025
CLARITHROMYCIN 500MG (CAP)
02/20/2025
03/05/2025
PO
500mg
BID
H Pylori Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes